Tripoli is evolving into a pharma hub

The industrial area of Tripoli, in central Peloponnese, is developing into a center for research and production of medicines, as investments amounting to 180 million euros are planned in the next period, creating more than 1,000 new direct jobs.

They are the investments of Greek pharmaceutical companies Demo, Win Medica of the Elpen group, as well as Faran that is planning a research and production unit for injectable and biotechnological drugs, with a total area of 12,000 square meters.

The amount of investment for the former two pharmaceutical industries amounts to €130 million, while, in total, the entire sector in the seven-year period 2021-2026 is expected to implement investments amounting to €1.2 billion.

In the context of the presentation of the investments by the three Greek pharmaceutical companies, Theodoros Tryfon, president of the Panhellenic...